抗生物質市場 - 成長、トレンド、COVID-19 の影響、および予測 (2023 - 2028)

Market Summary

The antibiotics market was valued at USD 47,150.78 million in 2021, and it is expected to reach USD 63,017.22 million by 2027, registering a CAGR of 5.10% during the forecast period.

COVID-19 impacted the global supply chain of pharmaceuticals, affecting the antibiotics market. However, many antibiotics were initially used to treat COVID-19 and are widely prescribed and studied as the COVID-19 remedy. For instance, in March 2020, Pfizer announced positive data for using its azithromycin (Zithromax) drug, along with hydroxychloroquine, in a coronavirus (COVID-19) clinical trial performed in France. There was a huge demand for antibiotics during the COVID-19 pandemic, which also impacted the studied market of antibiotics. For instance, according to a July 2021 published article titled, “Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis”, COVID-19 contributed to about 216 million excess doses of non-CAF (child-appropriate formulations) of antibiotics in total and 38 million excess doses of azithromycin between June and September 2020 in India.

The rising prevalence of bacterial infections and the need for effective and newer antibiotics are driving the demand for advanced antibiotics. For instance, according to the October 2021 report of the World Health Organization (WHO), about 1.5 million people worldwide died because of tuberculosis (TB) in 2020, and approximately 10 million people fell ill with TB globally. As per the same source from WHO, of the estimated new cases of tuberculosis in 2020, 1.1 million were in children, and 86% of the TB cases were reported from the 30 high TB burden countries. One-third of the total cases were reported from eight countries, including India, China, Indonesia, Philippines, Pakistan, Nigeria, Bangladesh, and South Africa.

With the urbanization and destruction of natural habitats, climate change, and changing ecosystems, the rate of emergence of infectious diseases has increased recently. The population group primarily affected by these infectious diseases is people aged 65 and more (geriatric population). They are more prone to contracting infection due to their less responsive immune system. Thus, the growing geriatric population around the world is further expected to increase the demand for antibiotics worldwide and augment the growth in the antibiotics market over the forecast period. For instance, as per the World Population Ageing Highlight 2020 report published by the United Nations, the global geriatric population is expected to increase from 727 million in 2020 to 1.5 billion by 2050, which is an almost two-fold increase as the share of the geriatric population in 2020 was about 9.3%, which is projected to increase to 16% by 2050. Thus, with the growing aging population, the burden of infectious diseases is expected to increase, complementing the growth of the studied market during the forecast period.

The emergence of anti-MRSA/VRE drugs, increasing awareness about infectious diseases, and the government’s initiatives in improving the availability of antibiotics around the world for various diseases are further expected to augment the growth of the antibiotics market. However, factors such as the growing prevalence of antibiotics resistance, regulatory constraints, and decreasing number of companies involved in the research of antibiotics are expected to impede the growth of the antibiotics market over the forecast period of the study.

レポートの範囲

抗生物質とは、細菌を殺すことによって感染症を治療するために使用される薬を指します。これらは、主に外来患者の設定で、細菌感染と戦うために世界中で最も処方されたコースの1つです。市場は、製品（セファロスポリン、ペニシリン、フルオロキノロン、マクロライド、カルバペネム、アミノグリコシド、スルホンアミド、およびその他の製品タイプ）、スペクトル（広域スペクトル抗体および狭スペクトル抗体）、および地理（北米、ヨーロッパ、アジア-太平洋、中東、アフリカ、および南アメリカ）。市場レポートはまた、世界の主要な地域にわたる17カ国の推定市場規模と傾向をカバーしています。レポートは、上記のセグメントの値（百万米ドル）を提供します。

Report scope can be customized per your requirements. Click here.

主要な市場動向

セファロスポリンは、予測期間にわたって抗生物質市場で主要な市場シェアを保持すると予想されます

To understand key trends, Download Sample Report